Improvement of Inpatient Psychiatric Facility Quality Reporting program measure: Screening for metabolic disorders through pharmacy collaborative practice agreement-Reference-Cited by-同舟云学术

Improvement of Inpatient Psychiatric Facility Quality Reporting program measure: Screening for metabolic disorders through pharmacy collaborative practice agreement

Published:2021-09 Issue:5 Volume:61 Page:e126-e131
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Leung Jonathan G.^ORCID,Owen Amanda^ORCID,Webb Andrew J.^ORCID,Johnson Emily K.^ORCID,Dively-White Melinda^ORCID,Kreps Michelle,Anderson Kendra K.^ORCID,Schak Kathryn M.

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference21 articles.

1. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis;Pillinger;Lancet Psychiatry,2020

2. Life expectancy among persons with schizophrenia or bipolar affective disorder;Laursen;Schizophr Res,2011

3. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis;Mitchell;Br J Psychiatry,2011

4. American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes;Diabetes Care. Consens dev conference on antipsychotic drugs and obesity and diabetes,2004

5. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia;Keepers;Am J Psychiatry,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studies;Journal of Global Health;2024-05-24

2. Role of Board‐Certified Psychiatric Pharmacists in child and adolescent psychiatry;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-09-26

3. “The Impact of Pharmacists Engaged in Collaborative Practice Agreements in the United States”;Journal of Pharmacy Practice;2022-07-19

4. Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study;International Journal of Clinical Pharmacy;2022-07-13